Massachusetts cannabis regulators are planning to test whether THC levels listed on marijuana products truly reflect what consumers are buying, following a commitment made late last year to tighten oversight of the industry.
The state’s Cannabis Control Commission (CCC) said it will begin auditing cannabis items sold in Massachusetts and take enforcement measures if laboratory findings differ significantly from the potency claims printed on packaging.
Travis Ahern, the CCC Executive Director, noted that ensuring marijuana products are correctly labeled supports the agency’s responsibility to provide residents with safe, fair, and reliable access to the legal cannabis market.
Under the commission’s guidelines, THC content shown on packaging must fall between 75% and 125% of the amount listed on the label while still meeting compliance standards. For instance, a product advertised as containing 15% THC would be considered compliant if testing shows potency between 11.25% and 18.75%. However, products with results falling far outside those limits could face regulatory consequences.
The newly formed commission also has authority to refer cases involving inaccurate labeling to the Massachusetts attorney general’s office for possible legal review.
Ahern stated that the initiative aims to strengthen public understanding while recognizing that THC levels can naturally fluctuate, especially in cannabis flower. He noted that potency may decline over time depending on storage conditions and other variables that influence product composition.
According to the CCC, officials developed the policy after reviewing regulations in other states, conducting research, and evaluating data gathered from Massachusetts’ 11 independent cannabis testing laboratories. The commission, however, has not identified which facilities will carry out the verification testing or whether any of the current commercial labs will be selected.
The auditing effort is one piece of a broader campaign to improve testing standards across the cannabis sector. Regulators have recently revised testing procedures, assembled a task force to evaluate laboratory operations, and introduced a requirement that testing facilities upload digital certificates of analysis with every product assessment.
Officials are also collaborating with Metrc, Massachusetts’ cannabis tracking platform, to make testing certificates available to the public.
The move follows mounting scrutiny over allegations that THC potency has been overstated in legal cannabis products. Industry participants and law enforcement officials have argued for years that some laboratories may report inflated figures, driven in part by consumer demand for stronger marijuana products and pressure from businesses competing in the marketplace.
These efforts to address any inconsistencies in product labels are likely to be welcomed by the wider marijuana industry, including established firms like TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF), so that consumer confidence in products obtained from licensed outlets can be boosted.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is powered by IBN
